Condition
Nocturnal Hypertension
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed1
Not Yet Recruiting1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06780865Not ApplicableNot Yet Recruiting
Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension
NCT04137549RecruitingPrimary
Registry Study on "Control Nocturnal Hypertension to Reach the Target "
NCT03050229Phase 4CompletedPrimary
SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
NCT01533584UnknownPrimary
Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage
Showing all 4 trials